Connection

Helmut Albrecht to Female

This is a "connection" page, showing publications Helmut Albrecht has written about Female.
Connection Strength

0.344
  1. HIV community viral load trends in South Carolina. Int J STD AIDS. 2017 03; 28(3):265-276.
    View in: PubMed
    Score: 0.029
  2. Sexual Orientation and Risk. Am J Public Health. 2015 Sep; 105(9):e6.
    View in: PubMed
    Score: 0.027
  3. Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases. South Med J. 2015 Mar; 108(3):180-8.
    View in: PubMed
    Score: 0.026
  4. Clostridium difficile: case report and concise review of fecal microbiota transplantation. J S C Med Assoc. 2013 Jun; 109(2):62-6.
    View in: PubMed
    Score: 0.023
  5. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms. Respir Res. 2012 Dec 27; 13:118.
    View in: PubMed
    Score: 0.023
  6. Barriers to care and service needs among chronically homeless persons in a housing first program. Prof Case Manag. 2012 Nov-Dec; 17(6):278-84.
    View in: PubMed
    Score: 0.022
  7. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):377-381.
    View in: PubMed
    Score: 0.011
  8. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2019 06; 6(6):e364-e372.
    View in: PubMed
    Score: 0.009
  9. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
    View in: PubMed
    Score: 0.009
  10. Cost-Effectiveness Analysis of Early vs Late Diagnosis of HIV-Infected Patients in South Carolina. South Med J. 2018 06; 111(6):355-358.
    View in: PubMed
    Score: 0.008
  11. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
    View in: PubMed
    Score: 0.008
  12. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
    View in: PubMed
    Score: 0.008
  13. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
    View in: PubMed
    Score: 0.008
  14. Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
    View in: PubMed
    Score: 0.007
  15. The South Carolina rural-urban HIV continuum of care. AIDS Care. 2017 07; 29(7):817-822.
    View in: PubMed
    Score: 0.007
  16. Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia. Infect Dis (Lond). 2017 May; 49(5):341-346.
    View in: PubMed
    Score: 0.007
  17. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
    View in: PubMed
    Score: 0.007
  18. Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
    View in: PubMed
    Score: 0.007
  19. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
    View in: PubMed
    Score: 0.007
  20. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
    View in: PubMed
    Score: 0.007
  21. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
    View in: PubMed
    Score: 0.007
  22. The South Carolina HIV Cascade of Care. South Med J. 2015 Nov; 108(11):670-4.
    View in: PubMed
    Score: 0.007
  23. Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina. AIDS Patient Care STDS. 2015 Jan; 29(1):26-32.
    View in: PubMed
    Score: 0.007
  24. Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review. BMJ Case Rep. 2014 Dec 12; 2014.
    View in: PubMed
    Score: 0.007
  25. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
    View in: PubMed
    Score: 0.006
  26. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults. Clin Cardiol. 2014 Sep; 37(9):517-22.
    View in: PubMed
    Score: 0.006
  27. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
    View in: PubMed
    Score: 0.006
  28. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011. Metab Syndr Relat Disord. 2013 Dec; 11(6):417-26.
    View in: PubMed
    Score: 0.006
  29. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009. South Med J. 2011 Feb; 104(2):95-101.
    View in: PubMed
    Score: 0.005
  30. Missed opportunities for early HIV diagnosis in correctional facilities. AIDS Patient Care STDS. 2009 Dec; 23(12):1025-32.
    View in: PubMed
    Score: 0.005
  31. Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals. AIDS Patient Care STDS. 2009 May; 23(5):339-45.
    View in: PubMed
    Score: 0.004
  32. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol. 2008 Apr 15; 180(8):5582-92.
    View in: PubMed
    Score: 0.004
  33. Epidemiological characterization of individuals with newly reported HIV infection: South Carolina, 2004-2005. Am J Public Health. 2009 Apr; 99 Suppl 1:S111-7.
    View in: PubMed
    Score: 0.004
  34. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol. 2005 Mar 01; 174(5):2900-9.
    View in: PubMed
    Score: 0.003
  35. Imported malaria at an inner-city hospital in the United States. Am J Med Sci. 2005 Jan; 329(1):6-12.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.